| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/23/2011 | EP2297148A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 03/23/2011 | EP2297147A1 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors |
| 03/23/2011 | EP2297146A1 Substituted quinazolines |
| 03/23/2011 | EP2297145A2 Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n- (1-methylpiperidin-4-yl)-9h-pyrido[2, 3-b]indole-7-carboxamide and methods of use therefor |
| 03/23/2011 | EP2297144A1 Imidazopyridine and related analogs as sirtuin modulators |
| 03/23/2011 | EP2297140A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof |
| 03/23/2011 | EP2297137A1 Novel heteroaryl carboxamide derivatives |
| 03/23/2011 | EP2297114A2 Heterocyclic compound and use thereof |
| 03/23/2011 | EP2297110A1 Indane derivatives as ampa receptor modulators |
| 03/23/2011 | EP2297107A1 Ý4-(1-amino-ethyl) -cyclohexyl¨-methyl-amine and ý6-(1-amino-ethyl) -tetrahydro- pyran-3-yl¨-methyl-amine derivatives as antibacterials |
| 03/23/2011 | EP2297106A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 03/23/2011 | EP2296653A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 03/23/2011 | EP2296651A1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases |
| 03/23/2011 | EP2296475A1 Triazolopyridine jak inhibitor compounds and methods |
| 03/23/2011 | EP2144909B1 [2,6]naphthyridines useful as protein kinase inhibitors |
| 03/23/2011 | EP2086643B1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 03/23/2011 | EP1983990B1 A3 adenosine receptor allosteric modulators |
| 03/23/2011 | CN101990539A Compounds and compositions as kinase inhibitors |
| 03/23/2011 | CN101990537A Amide derivatives as positive allosteric modulators and methods of use thereof |
| 03/23/2011 | CN101987849A Method of treatment of age-related macular degeneration(AMD) |
| 03/23/2011 | CN101175753B Compounds and compositions as protein kinase inhibitors |
| 03/22/2011 | US7910736 Method for producing organic field-effect transistors |
| 03/22/2011 | US7910602 treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction |
| 03/22/2011 | US7910601 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/22/2011 | US7910600 Therapeutic kinase modulators |
| 03/22/2011 | US7910597 platelet lowering agent anagrelide especially 3-and 5-substituted analogues, with reduced potential for cardiovascular side-effects; imidazo[2,1-b]quinazolin-2-one derivatives; by inhibiting megakaryocytopoeisis; antiproliferative agents |
| 03/22/2011 | US7910595 Anti-viral compounds |
| 03/22/2011 | US7910593 Water-soluble prodrugs |
| 03/22/2011 | US7910586 Drug screening; administering secretase inhibitor; Alzheimer's disease |
| 03/22/2011 | CA2614443C Pyrido [2,3-d] pyrimidine-2,4-diamine compounds as ptp1b inhibitors |
| 03/22/2011 | CA2521398C A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof |
| 03/22/2011 | CA2500824C Tricyclic tetrahydroquinoline antibacterial agents |
| 03/22/2011 | CA2490531C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/22/2011 | CA2480880C Inhibitors of akt activity |
| 03/22/2011 | CA2471628C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/17/2011 | WO2011031965A1 Modulators of toll-like receptors |
| 03/17/2011 | WO2011031818A2 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | WO2011031816A2 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | WO2011031745A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031744A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031743A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031740A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011030566A1 Phenanthroline derivatives and their use as ligands |
| 03/17/2011 | WO2011030349A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
| 03/17/2011 | WO2011030224A2 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities |
| 03/17/2011 | WO2011029920A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| 03/17/2011 | WO2011029855A1 Pyrrolo-pyridine derivatives as activators of ampk |
| 03/17/2011 | WO2011029842A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer |
| 03/17/2011 | WO2011029802A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/17/2011 | WO2011008312A3 Indole and indoline derivatives and methods of use thereof |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065915 Catalysts for metathesis reactions including enantioselective olefin metathesis, and related methods |
| 03/17/2011 | US20110065896 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 03/17/2011 | US20110065745 Polysubstituted 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |
| 03/17/2011 | US20110065728 Lipoprotein lipase-activating compositions comprising benzene derivatives |
| 03/17/2011 | US20110065727 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065714 Substituted quinazolines |
| 03/17/2011 | US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors |
| 03/17/2011 | US20110065712 Tricyclic compounds and pharmaceutical uses thereof |
| 03/17/2011 | US20110065702 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
| 03/17/2011 | US20110065700 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065699 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065696 Imidazoyl pyridine compounds and salts thereof |
| 03/17/2011 | US20110065687 Hydrazide compounds and uses thereof |
| 03/17/2011 | US20110065681 Amide compounds, compositions and uses thereof |
| 03/17/2011 | US20110065671 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 03/17/2011 | US20110064892 Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base |
| 03/17/2011 | US20110064698 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064693 Antiviral Drugs for Treatment of Arenavirus Infection |
| 03/17/2011 | US20110062429 Compound for organic electroluminescent device and organic electroluminescent device |
| 03/17/2011 | US20110061723 Dye sensitised solar cell |
| 03/17/2011 | CA2773848A1 Pi3 kinase inhibitors and uses thereof |
| 03/17/2011 | CA2772989A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer |
| 03/17/2011 | CA2772522A1 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | CA2772488A1 Heterocyclic derivatives as inhibitors of glutaminyl cyclase |
| 03/17/2011 | CA2772253A1 Modulators of toll-like receptors |
| 03/17/2011 | CA2771885A1 1,2-dihydro-2-oxoquinoline compounds as 5-ht4receptor ligands |
| 03/17/2011 | CA2770252A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295437A1 Diazabicyclic central nervous system active agents |
| 03/16/2011 | EP2295433A2 JNK inhibitors |
| 03/16/2011 | EP2294069A1 Therapeutically useful substituted hydropyrido ý3,2,1-ij¨quinoline compounds |
| 03/16/2011 | EP2294068A1 1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof |
| 03/16/2011 | EP2294054A1 A preparation method of (4s,5r)-semiester |
| 03/16/2011 | EP2294053A2 Glucokinase activators |
| 03/16/2011 | EP2293793A1 2,5-disubstituted imidazo[4,5-c]pyridines for treating muscular dystrophy |
| 03/16/2011 | EP2205562B1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 03/16/2011 | EP2167470B1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands |
| 03/16/2011 | EP1966198B1 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace) |
| 03/16/2011 | EP1699761B1 Cb1 modulator compounds |
| 03/16/2011 | CN101985448A Pharmaceutical intermediate pyridine[2,3-d]pyrimidine-4(3H)-ketone and preparation thereof |
| 03/16/2011 | CN101985437A Naphtha uracil peptide nucleic acid (PNA) monomer, intermediate thereof as well as preparation methods and applications thereof |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906648 Pyrrolo-pyridine kinase modulators |
| 03/15/2011 | US7906646 Spirocyclic heterocyclic derivatives and methods of their use |
| 03/15/2011 | US7906546 Tetrahydrocarbazoles and derivatives |
| 03/15/2011 | US7906530 1,7-naphthyridine derivatives as p38 MAP kinase inhibitors |
| 03/15/2011 | US7906528 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits |